ATLANTA, March 1, 2011 /PRNewswire/ -- Medication adherence alone may not be enough to impact the productivity of employees with chronic conditions such as depression, diabetes, hypertension and coronary artery disease. That key finding and others from a major research study will be previewed by Alere Health and other industry experts at the Integrated Benefits Institute (IBI) and National Business Coalition on Health (NBCH) Conference in San Francisco, Tuesday, March 1.
Alere Senior Healthcare Analyst Vince Haufle will co-present the overview along with other study authors. Key participants in the study include Alere, IBI and the American College of Occupational and Environmental Medicine (ACOEM). Funding for the study was provided by the National Pharmaceutical Council (NPC).
The new study is a follow up to the landmark 2009 study, "Health and Productivity as a Business Strategy," which demonstrated how, on average, health-related lost productivity costs are 2.3 times more than the medical and pharmacy costs for chronic conditions. That same study also recommended a further look at the impact of medication adherence on lost productivity.
At the IBI presentation, Haufle and his co-presenters will give an overview of the research to be published, which was gathered over a 12-month period and covers five large employers with more than 86,000 employees. The study looked at medication adherence, co-morbidity, health risks and other factors associated with workplace productivity. Researchers were surprised to find that medication adherence alone did not always equate with higher levels of productivity.
"This study provides evidence suggesting that among a largely medication-compliant group of employees with chronic health conditions, high modifiable health risk status remained a significant predictor of lower job performance (presenteeism) and th
|SOURCE Alere Health|
Copyright©2010 PR Newswire.
All rights reserved